CFG
BEAM icon

CKW Financial Group’s Beam Therapeutics BEAM Stock Holding History

CKW Financial Group’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-101
Closed -$6K – 209
2022
Q1 		$6K Hold
101
– – ﹤0.01% 177
2021
Q4 		$10K Hold
101
– – ﹤0.01% 178
2021
Q3 		$9K Hold
101
– – ﹤0.01% 190
2021
Q2 		$13K Hold
101
– – ﹤0.01% 187
2021
Q1 		$8K Hold
101
– – ﹤0.01% 168
2020
Q4 		$8K Hold
101
– – ﹤0.01% 156
2020
Q3 		$2K Buy
+101
New +$2.51K ﹤0.01% 162

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

CKW Financial Group's BEAM Position: Q2 2022 in Review

CKW Financial Group sold out of Beam Therapeutics (BEAM) in Q2 2022, closing a stake of 101 shares — an estimated $6K sold.

CKW Financial Group first reported a position in BEAM in Q3 2020 and held it in 7 quarters. The position peaked at $13K in Q2 2021. 205 funds tracked by Wall St. Rank hold BEAM as of Q2 2022.

  • CKW Financial Group reported no remaining Beam Therapeutics position as of Q2 2022 after selling out during the quarter.
  • CKW Financial Group sold 101 Beam Therapeutics shares in Q2 2022, an estimated $6K.
  • CKW Financial Group first reported a position in Beam Therapeutics in Q3 2020 and held it in 7 quarters.
  • CKW Financial Group's Beam Therapeutics position peaked at $13K in Q2 2021.
  • 205 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2022.

Based on CKW Financial Group's 13F filing for Q2 2022, filed 4 Aug 2022.